The FDA on 28 June 2013 approved Brisdelle (paroxetine)to treat moderate to severe hot flashes (vasomotor symptoms associated with Menopause)....
Results from two Phase III clinical studies of Brisdelle (paroxetine) capsules, from Noven Pharma, for the treatment of moderate to...
Noven Pharmaceuticals has announced the publication of data on the effects of Brisdelle (paroxetine) capsules, 7.5 mg, in the October...